<?xml version="1.0" encoding="UTF-8"?>
<p id="Par7" class="p">The above-mentioned issues together with increasing microbial resistance to antibiotics used in bone treatment (gentamycin, ciprofloxacin, rifampicin) prompted researchers to explore alternative new key molecules against bacterial species forming bone biofilm, with special stress placed on their anti-staphylococcal and anti-pseudomonal activity
 <sup class="sup">
  <xref ref-type="bibr" rid="CR20" class="xref">20</xref>
 </sup>.
</p>
